Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Good
|
New words:
analytical, argument, Baltimore, bankruptcy, blended, brighter, cite, cited, commonly, convincing, cured, deadline, deficiency, Delta, excipient, exhausted, expedient, foot, fora, heard, inclusive, insolvency, Lancet, Langone, mandatory, Maryland, matter, mentioned, NYU, open, persist, preponderance, proof, renewal, renewed, Respiratory, Silver, Spring, square, strike, substance, summer, TID, unpatentable, upheld, variant
Removed:
addressed, age, Alembic, biomarker, BPD, bronchopulmonary, cardiac, CHP, convenience, curtailed, derived, distance, dose, dysplasia, etiology, fibrosing, gender, IIP, irinotecan, multiple, NaN, Par, placebo, preterm, pursuing, Reddy, refractory, relapsed, satisfaction, satisfied, session, showed, space, Sterile, temozolomide, Teva, tolerated, transit, trough, Unexisome, USA, walk
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view